sank 22% after the tissue regeneration company missed third-quarter earnings targets and trimmed full-year guidance.
The Branchburg, N.J., company made $5.1 million, or 15 cents a share, for the quarter ended Sept. 30, up from the year-ago $2.5 million, or 7 cents a share.
Revenue rose to $35.3 million from $24.5 million a year earlier.
Analysts surveyed by Thomson Financial were looking for a 16-cent profit on sales of $34.7 million.
The company said it expects to make 57 cents to 59 cents a share for the year, down from its previous guidance of 59 cents to 63 cents.
Revenue should be $139 million, down from the previous $145.5 million target.
Shares fell $6.97 to $24.87.